PlainRecordsFDA drug shortage list
Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release
On FDA's list as to be discontinued: 2 packages from 1 company. Last updated by FDA June 15, 2026. Data from openFDA as of Nov. 12, 2026; FDA's own database can be newer. Not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.
Packages of this drug on FDA's current shortage list, as of openFDA's export of Nov. 12, 2026: none listed.
FDA lists it as to be discontinued.To be discontinued (2)
- Discontinued June 15, 2026Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)Amneal Pharmaceuticals
- Discontinued June 15, 2026Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)Amneal Pharmaceuticals
Every entry as FDA lists it (2)
To be discontinued (2)
Amneal Pharmaceuticals
Contact: 866-525-7270
- Discontinued June 15, 2026Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)Related information: Discontinuation of the manufacture of the drug
First posted June 15, 2026 · updated June 15, 2026 - Discontinued June 15, 2026Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)Related information: Discontinuation of the manufacture of the drug
First posted June 15, 2026 · updated June 15, 2026
Data provided by the U.S. Food and Drug Administration through openFDA, as of Nov. 12, 2026; FDA's drug shortage database can be newer. openFDA's own note on this data: "Do not rely on openFDA to make decisions regarding medical care." This is not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.